about
Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complexGenetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsal-ventral axis in the limbImpact of diabetes type II and chronic inflammation on pancreatic cancer.Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancerRisk factors for pancreatic ductal adenocarcinoma specifically stimulate pancreatic duct glands in mice.Binding versus Conventional Pancreaticojejunostomy in Preventing Postoperative Pancreatic Fistula: A Systematic Review and Meta-Analysis.Analysis of Axin2 expression and function in murine models for pancreatic cancer.Erythropoietin improves skin wound healing and activates the TGF-β signaling pathway.Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin.Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines.Diabetes increases pancreatitis induced systemic inflammation but has little effect on inflammation and cell death in the lung.Melatonin restores muscle regeneration and enhances muscle function after crush injury in rats.Impact of hyperglycemia and acute pancreatitis on the receptor for advanced glycation endproductsDarbepoetin-α inhibits the perpetuation of necro-inflammation and delays the progression of cholestatic fibrosis in mice.Bmp and Wnt/beta-catenin signals control expression of the transcription factor Olig3 and the specification of spinal cord neurons.α-cyano-4-hydroxycinnamate impairs pancreatic cancer cells by stimulating the p38 signaling pathway.The Ambivalent Function of YAP in Apoptosis and CancerDiabetes aggravates acute pancreatitis and inhibits pancreas regeneration in miceDiabetes increases pancreatic fibrosis during chronic inflammationBenefits of non-invasive methods compared to telemetry for distress analysis in a murine model of pancreatic cancerDefining body-weight reduction as a humane endpoint: a critical appraisalA safe bet? Inter-laboratory variability in behaviour-based severity assessmentWhere are we heading? Challenges in evidence-based severity assessmentGrading Distress of Different Animal Models for Gastrointestinal Diseases Based on Plasma Corticosterone Kinetics
P50
Q24292279-60615874-B01F-4897-BE52-558E4CEB916CQ28507152-1E8AEFAE-984A-403D-8B5A-672CD45414D5Q34669348-D2F7372B-ACF1-49C1-93DA-E7E2571F30EAQ36001882-ACE0E175-32A2-41AB-B261-E56CD5320BC8Q38317476-6BD6E528-FC2E-4673-82C0-EBF5A776264EQ39092111-4459863E-3E4A-4842-AEC6-22A5F941E012Q39459109-9CAFE7CB-EA5A-4BBC-9CEB-97AB8D2E152CQ39479209-0AD63FD8-6012-493D-9A9E-6B254E643B9EQ39529888-856014F3-0DC9-423E-AAEF-EEC846F5C636Q41395916-B61061FA-FB64-467F-855D-69C353BCCE4AQ41659055-9DB6E6CC-A450-45F7-9B85-F354EFE019EDQ42610763-76CBA1E1-ACA6-4878-A93A-5C5F14A8267EQ42672104-AD0A10E9-A7AA-4EA3-A484-0EFED7605E67Q43010284-078B326B-D997-4A53-9E94-B1D778B47D08Q51999950-6A6A199D-DA78-4B88-9855-A45449B96CADQ52612922-BFB01B75-2FAA-4C71-967B-49CAFABEA72BQ60935295-20D9B2DD-42A8-4923-88E5-B8CC0509BC7CQ83428006-FED97E46-D303-43A3-ABF8-D5E4A52BB93FQ87651497-9B76153A-1C0F-4D00-B13E-DE9043F8E182Q90888572-CC5FC58B-7CEE-4280-ACD9-2EC456867871Q91009095-58D06C55-7206-49AA-8204-B0CEC4B3D67CQ91160078-10C4B81F-33AD-4330-A705-34F938113937Q91256386-0911B826-D151-4DD5-BF9B-D3A9BF2EE88EQ93104535-08E4218D-1BE5-4CF3-B50E-7E497F95DB11
P50
description
researcher
@en
name
Dietmar Zechner
@en
Dietmar Zechner
@nl
type
label
Dietmar Zechner
@en
Dietmar Zechner
@nl
prefLabel
Dietmar Zechner
@en
Dietmar Zechner
@nl
P106
P31
P496
0000-0002-2075-7540